Synmosa Biopharma Corp 2025 Annual Report with Sustainability Disclosures
Company: Synmosa Biopharma Corp
Sector: Manufacturing
Country: Taiwan
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 175
The report records near-12% growth in consolidated revenue in 2025. It highlights the launch of a six-year International Upgrade Plan and the establishment of the Korean subsidiary as a foothold for Asia-Pacific expansion. The report also describes the creation of a Board-level Sustainable Development Committee and notes that women account for 25% of board seats excluding one vacancy.
Services
From bulk PDFs to structured indicators and machine-readable documents.